Get the Stockscreener App
6.78
0.15%
-0.010
Pepgen Inc stock is traded at $6.78, with a volume of 9,778.
It is down -0.15% in the last 24 hours and down -27.10% over the past month.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
See More
Previous Close:
$6.79
Open:
$6.735
24h Volume:
9,778
Relative Volume:
0.09
Market Cap:
$221.28M
Revenue:
-
Net Income/Loss:
$-78.63M
P/E Ratio:
-2.3141
EPS:
-2.9299
Net Cash Flow:
$-71.60M
1W Performance:
-6.87%
1M Performance:
-27.10%
6M Performance:
-52.25%
1Y Performance:
+29.39%
1-Day Range:
$6.63
$6.85
1-Week Range:
$6.36
$7.4899
52-Week Range:
$3.72
$19.30
Pepgen Inc Stock (PEPG) Company Profile
Name
Pepgen Inc
Sector
Industry
Phone
703-456-8000
Address
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-21-22 | Initiated | H.C. Wainwright | Buy |
Pepgen Inc Stock (PEPG) Latest News
PepGen to Participate in Upcoming Investor Conferences - Business Wire
(PEPG) Technical Data - Stock Traders Daily
(PEPG) Proactive Strategies - Stock Traders Daily
PepGen Announces Presentations at the 29th Annual Congress of the World Muscle Society - Business Wire
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher - Benzinga
When the Price of (PEPG) Talks, People Listen - Stock Traders Daily
PepGen Inc. Announces Christopher Ashton to Retire from Its Board of Directors, Effective September 30, 2024 - Marketscreener.com
PepGen director Christopher Ashton to retire at month's end - Investing.com
PepGen director Christopher Ashton to retire at month's end By Investing.com - Investing.com Australia
PepGen Inc. Board Reshuffles as Ashton Plans Retirement - TipRanks
PepGen Announces Christopher Ashton, PhD, to Retire from its Board of Directors - Business Wire
Sofinnova Investments Inc. Has $8.96 Million Holdings in PepGen Inc. (NASDAQ:PEPG) - MarketBeat
Investigation announced for Investors who lost money with - openPR
Trend Tracker for (PEPG) - Stock Traders Daily
PepGen Inc [NASDAQ: PEPG] Sees Decrease in Stock Value - Knox Daily
PepGen (NASDAQ:PEPG) Trading Down 0.4% - MarketBeat
(PEPG) Long Term Investment Analysis - Stock Traders Daily
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & Development - Manchestertimes
PepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & Development - Business Wire
The PepGen Inc (PEPG) had a good session last reading, didn’t it? - US Post News
A company insider recently sold 7,571 shares of PepGen Inc [PEPG]. Should You Sale? - Knox Daily
Metric Analysis: PepGen Inc (PEPG)’s Key Ratios in the Limelight - The Dwinnex
PepGen Inc (PEPG) Stock: A Year of Declines and Increases - The InvestChronicle
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - AccessWire
Vanguard Group Inc. Purchases 344,266 Shares of PepGen Inc. (NASDAQ:PEPG) - Defense World
PepGen Inc. (NASDAQ:PEPG) Shares Purchased by Vanguard Group Inc. - MarketBeat
Investors Welcome To Participate In The Schall Law Firm's Securities Fraud Investigation Into PepGen Inc - WICZ
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & - GlobeNewswire
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - GlobeNewswire Inc.
FY2027 Earnings Forecast for PepGen Inc. Issued By HC Wainwright (NASDAQ:PEPG) - MarketBeat
FY2027 Earnings Estimate for PepGen Inc. (NASDAQ:PEPG) Issued By HC Wainwright - Defense World
PepGen Inc. Forecasted to Earn Q3 2024 Earnings of ($0.90) Per Share (NASDAQ:PEPG) - Defense World
Comparing PepGen (NASDAQ:PEPG) and Bicycle Therapeutics (NASDAQ:BCYC) - Defense World
PepGen Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - Business Wire
PEPG Investors Can Participate In The PepGen Inc Securities Fraud Investigation With The Schall Law Firm - AccessWire
PEPG (PepGen Inc) may reap gains as insiders became active recently - Knox Daily
Objective long/short (PEPG) Report - Stock Traders Daily
PepGen (NASDAQ:PEPG) Earns “Buy” Rating from HC Wainwright - American Banking and Market News
PepGen (NASDAQ:PEPG) Stock Rating Reaffirmed by HC Wainwright - Defense World
Down -39.63% in 4 Weeks, Here's Why You Should You Buy the Dip in PepGen (PEPG) - MSN
Bank of America Downgrades PepGen (NASDAQ:PEPG) to Neutral - Defense World
PepGen Inc [PEPG] Chief Medical Officer makes an insider purchase of 7,571 shares worth 0.14 million. - Knox Daily
PepGen (NASDAQ:PEPG) Given "Buy" Rating at HC Wainwright - MarketBeat
Janus Henderson Group PLC Has $17.23 Million Stock Holdings in PepGen Inc. (NASDAQ:PEPG) - MarketBeat
PEPG Stock Update: PepGen Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
Closing Figures: PepGen Inc (PEPG)’s Negative Finish at 11.43, Down -32.69 - The Dwinnex
PepGen (NASDAQ:PEPG) Rating Reiterated by Wedbush - MarketBeat
RPD Investors Have the Opportunity to Join Investigation of Rapid7, Inc. with the Schall Law Firm - Business Wire
CRWD Investors Have Opportunity to Lead CrowdStrike Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
Mayday, skipper: Pepgen shares run aground on DMD phase II data - BioWorld Online
Nasdaq Surges Over 3%; Powell Industries Shares Spike Higher - Benzinga
Pepgen Inc Stock (PEPG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):